Perflow Medical News
8 articles
growth-positive
Chinese fund buys Perflow Medical for $100m
Israeli medical device company Perflow Medical has been acquired by an unnamed Chinese private equity firm for approximately $100 million. Perflow Medical develops neurovascular treatments for hemorrhagic and ischemic strokes. The company was founded in 2014 and has raised $17 million to date. This is the second exit for CEO Danny Farin, who previously managed EON Surgical. Perflow Medicals innovative technology allows doctors to precisely control the diameter of the mesh and remove blood clots from the brains blood vessels. Their first device has received EU clearance but is awaiting FDA approval for the US market.
Acquisition
growth-positive
Perflow Medical Expands Product Portfolio with First Clinical Use of the Stream™17 Dynamic Neuro-Thrombectomy Net
Perflow Medical has announced the successful clinical use of the Stream17 Dynamic Neuro-Thrombectomy Net, a device designed for neurovascular treatments. The device, built on Perflows proprietary CEREBRAL NET technology, expands the range of brain vessels that can be treated. The first clinical procedures were completed by Prof. Karlis Kupcs in Latvia. The company also offers the Cascade17 Dynamic Non-Occlusive Remodeling Net for coil embolization of intracranial aneurysms. Perflows products are commercially available in Europe but not yet cleared for use in the United States.
Customers
growth-positive
Perflow Medical Announces the First Clinical Use of the Cascade™ 17 Dynamic Non-Occlusive Remodeling Net
Perflow Medical has launched the Cascade 17 Non-Occlusive Remodeling Net in the European market. The Cascade17 is a neurovascular device that optimizes non-occlusive support during coil embolization of intracranial aneurysms. It is based on Perflows proprietary CEREBRAL NET technology. The device enables continuous blood flow during cerebral aneurysm repair and coiling, potentially improving patient outcomes. Early clinical experience with the Cascade17 has been promising. Perflow Medical plans to launch more products, including the Stream17 Dynamic Neuro-Thrombectomy Net. The Cascade Net and Stream Net product families are available in Europe, but not yet approved for clinical use in the United States.
Customers
growth-positive
Perflow Medical Receives CE Mark Approval of Novel Cascade™ Agile BioSpace
Perflow Medical has received CE Mark approval for the Cascade Agile Non-Occlusive Remodeling Net, expanding their product family for neurovascular treatment. The Cascade Agile provides better control for distal and tortuous vessel anatomy during coil embolization of intracranial aneurysms. Perflow Medical also published an article highlighting the clinical experience with the Cascade Net for the treatment of ruptured intercranial aneurysms. The companys focus on providing physicians with more intraoperative control and better information has been well received by the market. Perflow Medical plans to publish their clinical experience with the Stream and Cascade Net, fueling future commercial expansion. The Cascade product family and Stream Net are commercially available in Europe, but not approved for clinical use in the United States.
Customers
growth-positive
Perflow Medical Expands IP Coverage for Novel Stream™ Dynamic Neuro-Thrombectomy Net Device and Cascade™ Non-Occlusive Remodeling Net
Perflow Medical, an Israeli-based medtech company, has announced the issuance of four international patents that expand its global intellectual property (IP) coverage for its neuro-interventional devices. The companys growing portfolio now includes eight issued patents, with two new patents from the European Patent Office, one from the China National Intellectual Property Administration, and one from the Japanese Patent Office. Perflow Medicals CEREBRAL NET technology platform, which includes the Stream and Cascade devices, offers real-time control and improved device performance for the treatment of complex neurovascular disorders. The company currently has two commercial products available in Europe and is focused on expanding its global reach. Clinical experience with the Stream and Cascade devices will be presented at the ABC-WIN Seminar in January 2019.
PartnersCustomers
Perflow Medical Announces the First Clinical Use of the Cascade™ Dynamic Non-Occlusive Remodeling Net
growth-positive
Perflow Medical Closes $12M Financing Round - FinSMEs
Perflow Medical, a medical device company based in Tel Aviv, Israel, has closed a $12 million financing round. The funds will be used to commercialize their first product, the Stream Net device, in Europe and other countries, as well as to submit a U.S. FDA 510(k) dossier and develop two new products. Perflow Medical develops innovative tools for neurovascular interventions and its patent-protected CEREBRAL NET™ Technology platform enables adjustable neurovascular treatments.
InvestmentExpand
growth-positive
Perflow Medical Announces Issuance of Patent for The Stream™ Dynamic Neuro-Thrombectomy Net to Improve Thrombus Removal Post-Stroke
Perflow Medical has announced the issuance of a US patent for their Stream Dynamic Neuro-Thrombectomy Net, the first device to provide full dynamic wall apposition during the treatment of acute ischemic stroke. The device allows physicians to have full control of the radiopaque, braided net to make real-time adjustments based on intracranial vessel geometry. This technology aims to improve patient outcomes by leveraging the physicians expertise and experience. The Stream Net is approved in Europe for the endovascular treatment of acute ischemic stroke.
Customers
